6:01 AM ET
8-K
Leadership Change
Eloxx Pharmaceuticals Leadership Change
Eloxx Pharmaceuticals has expanded its Board of Directors from five to six members and appointed Geno J. Germano as an independent director. Mr. Germano is a 35-year pharmaceutical industry veteran who previously served as CEO of Elucida Oncology and Group President at Pfizer. He will serve a term expiring at the company's 2027 annual meeting of stockholders.